Navigation Links
AST Concerned That Kidney Transplant Patients May Suffer Politics As Usual in Capitol Hill Health Care Reform Debate
Date:12/15/2009

WASHINGTON, Dec. 15 /PRNewswire-USNewswire/ -- Today's New York Times article by Kevin Sack, "Plan for Kidney Drugs Spurs Division," illustrates an internal renal community reimbursement debate that may result in kidney patients continuing to be deprived of their life-saving immunosuppressive medications beyond the current 36-month Medicare program limit.

As Congress is poised to approve this urgent transplant patient coverage to preserve the lives of transplant kidney recipients, behind-the-scenes debate continues within the renal community regarding how dialysis should be reimbursed. The American Society of Transplantation (AST) believes strongly that dialysis reimbursement, while important, should not hold hostage a bill that would provide thousands of kidney transplant patients their desperately needed and life-saving immunosuppressant medications.

AST President, Dr. Joren Madsen, stated this morning, "I applaud the New York Times for drawing attention to an urgent patient care issue which should not fall victim to politics as usual." Transplant patient immunosuppressive drug coverage has been AST's #1 Public Policy Issue for more than a decade. As this morning's New York Times article states, "It is pound foolish" to pay for a patient's organ transplant and then only give them a 36-month supply of the drugs they need to maintain their life-saving donor organ for the remainder of their life.

About AST

The American Society of Transplantation is an international organization of transplant professionals dedicated to advancing the field of transplanta
'/>"/>

SOURCE The American Society of Transplantation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. ACC Concerned Over Reporting of Biomonitoring Results
2. Methodist Dallas Medical Center First in Metroplex to Perform Kidney Transplant on HIV Positive Patient
3. FDA: Byetta Label Revised to Include Safety Information on Possible Kidney Problems
4. Quark Pharmaceuticals to Present Data on its siRNA Therapeutic Programs in Kidney and Lung Diseases
5. FDA Approves New Treatment for Advanced Form of Kidney Cancer
6. Satellite Healthcare Tees Up With the National Kidney Foundation in Santa Cruz, CA
7. Study Suggests that NGAL Identifies Acute Kidney Injury Early in ICU Patients
8. Bayers Novel Anti-Cancer Compound Regorafenib (BAY 73-4506) Showed Stabilization or Regression in 81 Percent of Kidney Cancer Patients
9. Keryx Biopharmaceuticals Phase 2 Data of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Renal Cell Cancer Selected for Oral Presentation at the Eighth International Kidney Cancer Symposium
10. WORLDS First Robotic Assisted Kidney Transplant Performed at Saint Barnabas Medical Center
11. Living Donor Kidney Transplants Using Alemtuzumab Pre-Conditioning and Tacrolimus Monotherapy: Long-Term Safety and Efficacy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... -- Integrity Applications, Inc. (OTCQB: IGAP) (the "Company" or ... a noninvasive  device that tracks blood glucose levels, announced today ... its new scientific advisory board that is expected to ... research, monitoring and treatment. Prof. Dr. ... and Head, Business Development of Profil Institute for Metabolic ...
(Date:2/26/2015)... , Feb. 26, 2015 People ... have the opportunity to participate in research that ... the first independent U.S. psoriasis registry begins recruiting ... joint collaboration with the National Psoriasis Foundation and ... reporting for secukinumab, a new biologic medication by ...
(Date:2/26/2015)... , Feb. 26, 2015 Surna Inc. ... specializing in commercial indoor cannabis cultivation technology, announced ... from start-up to fast-paced manufacturing and engineering company. ... , current Director and CEO, will be stepping ... proud of what the team has accomplished thus ...
Breaking Medicine Technology:Integrity Applications Names Prof. Lutz Heinemann to Advisory Board 2Integrity Applications Names Prof. Lutz Heinemann to Advisory Board 3Integrity Applications Names Prof. Lutz Heinemann to Advisory Board 4First independent U.S. psoriasis registry will track drug safety and effectiveness 2First independent U.S. psoriasis registry will track drug safety and effectiveness 3Surna, Inc. Announces Senior Leadership Changes 2Surna, Inc. Announces Senior Leadership Changes 3Surna, Inc. Announces Senior Leadership Changes 4
... 1, 2011 PTC Therapeutics, Inc. (PTC) today announced ... of ataluren, an investigational new drug, in adults with ... Respiratory Journal . The published three-month data showed that ... chloride channel activity, CF-related cough and positive trends in ...
... READING, England and BEDMINSTER, N.J., June 30, 2011 ... Inc., today announced that the U.S. Food and Drug ... the management of breakthrough pain in cancer patients 18 ... and who are tolerant to opioid therapy for their ...
Cached Medicine Technology:Ataluren Phase 2 Data in Nonsense Mutation Cystic Fibrosis Published in the European Respiratory Journal 2Ataluren Phase 2 Data in Nonsense Mutation Cystic Fibrosis Published in the European Respiratory Journal 3Ataluren Phase 2 Data in Nonsense Mutation Cystic Fibrosis Published in the European Respiratory Journal 4Ataluren Phase 2 Data in Nonsense Mutation Cystic Fibrosis Published in the European Respiratory Journal 5Ataluren Phase 2 Data in Nonsense Mutation Cystic Fibrosis Published in the European Respiratory Journal 6FDA Approves Lazanda® - First Fentanyl Nasal Spray - for the Management of Breakthrough Pain in Cancer Patients 2FDA Approves Lazanda® - First Fentanyl Nasal Spray - for the Management of Breakthrough Pain in Cancer Patients 3FDA Approves Lazanda® - First Fentanyl Nasal Spray - for the Management of Breakthrough Pain in Cancer Patients 4FDA Approves Lazanda® - First Fentanyl Nasal Spray - for the Management of Breakthrough Pain in Cancer Patients 5FDA Approves Lazanda® - First Fentanyl Nasal Spray - for the Management of Breakthrough Pain in Cancer Patients 6FDA Approves Lazanda® - First Fentanyl Nasal Spray - for the Management of Breakthrough Pain in Cancer Patients 7FDA Approves Lazanda® - First Fentanyl Nasal Spray - for the Management of Breakthrough Pain in Cancer Patients 8
(Date:2/26/2015)... Imagine a day without access to clean, drinkable water ... was no one to help. For more than 783 million ... more than 2.5 billion people will also lack access to ... initiative led by Nevada’s Desert Research Institute (DRI) ... women – who often bear the brunt of the impact ...
(Date:2/26/2015)... (PRWEB) February 26, 2015 The COR ... Topical BioMedics, Inc., Rhinebeck, NY, to offer customers a ... topical biomedicine formulas that safely and effectively address muscle, ... new division of Vets Access LLC, Montrose, MI, that ... healing products. , Topical BioMedics is a research and ...
(Date:2/26/2015)... NJ (PRWEB) February 26, 2015 The ... reopening of their newly renovated office in Lawrenceville, NJ. ... Reproductive Science Center of New Jersey’s physicians, and NJ ... and patient care in the areas of infertility and ... for having excellent success rates and providing current, high ...
(Date:2/26/2015)... Beckman Coulter is sponsoring a ... their cargo in cell-to-cell communication,” which will focus on ... cell-to-cell communication. The webinar is free to attend and ... PT. , Every cell in the body can release ... called “exosomes” or “microvesicles.” These vesicles carry a wide ...
(Date:2/26/2015)... February 26, 2015 Body Well Therapy, a ... years of delivering high quality mobile massage services ... other regions across the United States. The company has experienced ... pivotal year as it sets its sights on additional major ... chair massage services. , “We’ve come a long way since ...
Breaking Medicine News(10 mins):Health News:DRI launches Global Initiative to Provide Women in Developing Countries with Clean Water 2Health News:DRI launches Global Initiative to Provide Women in Developing Countries with Clean Water 3Health News:COR HEALTH Division of Vets Access Partners with Topical BioMedics to Provide Natural Pain Relief Products 2Health News:COR HEALTH Division of Vets Access Partners with Topical BioMedics to Provide Natural Pain Relief Products 3Health News:RSCNJ Is Celebrating the Reopening of Their Newly Renovated Office 2Health News:RSCNJ Is Celebrating the Reopening of Their Newly Renovated Office 3Health News:Beckman Coulter Webinar Series Presents Diversity of Extracellular Vesicles and Their Cargo in Cell-to-cell Communication 2Health News:Beckman Coulter Webinar Series Presents Diversity of Extracellular Vesicles and Their Cargo in Cell-to-cell Communication 3Health News:Body Well Therapy Celebrates 10 Years of Quality Mobile Massage Services 2Health News:Body Well Therapy Celebrates 10 Years of Quality Mobile Massage Services 3
... ... as a director of accounting. , ... Tucson, Ariz. (Vocus) June 16, 2010 -- Ray Brogan, former controller ... Brogan has more than 30 years of experience in financial reporting, budget analysis and ...
... tamoxifen for early-stage breast cancer who developed blood clots were ... women taking tamoxifen who did not develop blood clots, according ... Journal of the National Cancer Institute. Tamoxifen ... and post menopausal patients with hormone receptor-positive breast cancer. One ...
... of Gothenburg, Sweden, explores how an online learning community ... that clear rules facilitate continued web interaction. , ... how a large group of general practitioners interact via ... serves as an online community for exchange of knowledge ...
... American Society for Radiation Oncology (ASTRO) commends the Medicare ... self-referral in cancer care in its report released yesterday. ... to end abuses of the physician self-referral law in ... , "We are very pleased that ...
... immune system to attack healthy cells, study finds , ... finds that rare gene variations are more common in ... the body. These autoimmune disorders include rheumatoid arthritis and ... could lead to better treatments -- although that,s not ...
... remains lethal in a majority of cases, due to late ... LaBaer of the Biodesign Institute at Arizona State University, along ... Hutchinson Cancer Research Center in Seattle, used a novel ... cancer before symptoms appear. The work, which appeared ...
Cached Medicine News:Health News:New Director of Accounting Adds to Talent at Splendido Retirement Community 2Health News:Gene mutation increases thromboembolism risk in women taking tamoxifen 2Health News:Clear rules facilitate continued Web interaction among general practitioners 2Health News:ASTRO applauds MedPAC review of Stark law exception 2Health News:Gene Mutations Offer Clues to Autoimmune Disorders 2Health News:Blood relations 2Health News:Blood relations 3
... Shoulder Holder is used for positioning the ... position. The shoulder holder is adjustable with ... arm positions and sizes. The MITT allows ... arm in the shoulder holder during surgery. ...
Micro instruments designed to provide maximum grasping, resecting capability, and excellent maneuverability for easy access to tight, small joints (wrist, elbow, and ankle).,Features pinless hinge d...
Made exclusively from LactoSorb® Resorbable Copolymer....
The Stryker Bioabsorbable Wedge Interference Screw is made of Poly-L Lactic Acid (PLLA). The patented wedge design makes it perfect for cruciate reconstruction and is indicated for BTB and soft tissu...
Medicine Products: